Part 1: Parasitic infections -- Satranidazole and my pharmaceutical research odyssey: a success story -- Amoebiasis revisited -- Cerebral malaria: players in the pathogenic mechanism and treatment strategies -- Role of white blood cells in immunopathogenesis of cerebral malaria -- Chemotherapy and experimental models of visceral leishmaniasis -- Human trichomoniasis -- Taeniasis and neurocysticercosis: emerging public health problems -- Helminth parasites: the cause of distress and diseases -- Neglected tropical diseases: a biosocial perspective. Part 2: Bacterial infections -- Autophagy: a potential anti-bacterial therapeutic target -- Antibiotics and antimicrobial resistance -- Nontuberculous mycobacteria: an update on infections caused, laboratory identification and their treatment -- Drugs under pre-clinical and clinical testing for the treatment of infections caused due to Staphylococcus aureus: an update -- Recurrent vulvovaginal infections: etiology, diagnosis, treatment and management -- Enterococci as nosocomial pathogen -- Dietary antioxidants and infectious diseases -- Probiotic lactobacilli, infection and immunomodulation -- Part 3: Viral infections -- HIV-AIDS: an unconquered immune-war -- Chikungunya fever: where are we today? - Epigenetics and infectious pathogens: interactions, ploy and perspectives -- Part 4: Fungal infections -- An update on sexually transmitted infections: an Indian context -- Candida: friend and foe of humans.